33 results about "Cerebral vascular resistance" patented technology

The present invention relates to a medicine composition for curing angiocardiopathy and cerebrovascular disease. Said medicine composition contains ginsenoside and breviscapine.

The present invention provides medicinal application of cnidium officinale lactone A, medicine composition containing said cnidium officinal lactone A and their preparation method. Said cnidium officinal lactone A has the functions of increasing volume of blood flow of brain, reducing vascular resistance of brain and inhibiting thrombosis, so that it can be used for curing cerebrovascular disease.

The invention relates to a traditional Chinese medicinal combination containing propolis. The traditional Chinese medicinal combination consists of the following components in parts by weight: 240-960 parts of propolis powder, 26-104 parts of folium ginkgo extract, 26-104 parts of starch, 6-24 parts of superfine silica powder and 2-8 parts of magnesium stearate. The traditional Chinese medicinal combination has the beneficial effects of increasing the cerebrovascular flow, reducing the cerebrovascular resistance, improving the cerebrovascular circulation function, protecting brain cells from ischemic injury, expanding coronary arteries, preventing stenocardia and myocardial infarction, suppressing aggregation of blood platelets, preventing formation of thrombus, eliminating harmful oxyradical and improving the immunity, has cancer preventing and aging preventing functions and has magic treating effects of treating coronary heart diseases, stenocardia, cerebral arteriosclerosis, alzheimer diseases, hypertension and the like. The traditional Chinese medicinal combination can be applied to respective fields of pharmacy, health-protection substances, daily necessities, cosmetics and the like.

The invention provides a brain tonic medicament which comprises the following raw materials (by weight portion): gastrodia elata 20-90 parts, notoginseng 5-40 parts, ginkgo leaf 5-30 parts, walnut kernel 0-30 parts, ophiopogon root 5-50 parts, ichih fruit 5-40 parts and schisandra fruit 5-60 parts.

The Chinese patent medicine for curing hemiparalysis from apoplexy-"Fuzheng Piantanwan" pil is made from 13 Chinese medicinal materials of nux vomica, large gentian root, achryanthes root, scorpion, astragalus root, black-striped snake and others. Said invented medicine possesses the functions of improving blood circulation, reducing vascular resistance and increasing volume of blood flow. Its curative rate is up to above 96.5%.

The invention relates to the field of a traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following materials in parts by weight: 1-99 parts of rhizoma acori graminei, 1-99 parts of radix curcumae, 1-99 parts of coptis chinensis, 1-99 parts of ligusticum wallichii, 1-99 parts of wined rheum officinale, 1-99 parts of borneol, 1-99 parts of polygala tenuifolia, 1-99 parts of ground beeltle and 1-99 parts of arisaema cum bile. Ingestion of lead in use of medicines is avoided by omitting lithargite used as an adjuvant drug in the traditional prescription; the risk of lead poisoning is reduced. An experiment result shows that compared with the traditional prescription, the traditional Chinese medicine composition provided by the invention does not generate a significant difference on the influence of cerebral injuries of reperfusion rats or animal cerebral blood flow and cerebral vascular resistance; the traditional Chinese medicine composition provided by the invention does not display acute toxicity on the mice by an acute toxicity test.

A Chinese medicine for treating cardiovascular and cerebrovascular diseases with high curative effect is prepared from 18 Chinese-medicinal materials including astragalus root, red sage root, notoginseng, saffron, etc.

The present invention relates to the new use of natural plant extract in preparing medicine, and is especially the application of speedwell extract in preparing medicine for treating cerebral apoplexy. The speedwell extract is fluid extractum or extractum powder prepared with speedwell as material and through hot water or alcohol extraction. Animal experiments show that the speedwell extract has the functions of treating cerebral ischemia of rat, protecting rat with cerebral ischemia against re-perfusion damage, increasing the narcosis CBF of dog, lowering the CVR of dog, inhibiting platelet coagulation, etc. without toxicity.

The invention discloses a medicine for treating middle and terminal hypertension. The medicine is prepared from the following raw materials in parts by weight: 20-30 parts of prepared rehmannia root, 10-15 parts of Chinese yam, 10-15 parts of dogwood, 8-12 parts of moutan bark, 8-12 parts of rhizoma alismatis, 8-12 parts of poria coco, 10-15 parts of fruits of Chinese wolfberries, 8-12 parts of chrysanthemum flowers, 10-15 parts of the root of bidentate achyranthes, 10-20 parts of tortoise plastron, 8-12 parts of gastrodia elata, and 10-15 parts of folium mori. The medicine is prepared from 12 natural traditional Chinese medicines through mixing, the traditional Chinese medicines synergistically act to achieve the efficacies of enriching the blood and nourishing, tonifying deficiency and resisting aging, benefiting qi and nourishing blood, strengthening body resistance and eliminating pathogenic factors, activating blood circulation to dissipate stasis, reducing blood pressure, reducing blood vessel resistance, contracting blood vessels slightly, increasing the flow of coronary arteries, and the like, the medicine can treat both causes and symptoms of diseases, and is good in effect in treating middle and terminal hypertension, and free of toxic or side effect. A preparation is simple, the course of treatment is short, the administration is convenient, the cost is low, and the effective rate achieves 90% or above.

The invention belongs to the field of medicine technology, particularly relating to a medicine composition used for treating cardiovascular disease, the preparation method and usage thereof as well as the preparations containing the medicine composition. The composition of the raw materials of the effective components of the medicine composition is: 125-2000 portions of kudzuvine root and 100-2000 portions of snakegourd fruit, or 4-100 portions of kudzuvine root extract and 2-160 portions of snakegourd fruit extract. The medicine composition can be prepared into any preparation formulation acceptable in pharmacy, but injection or oral preparation is preferred. The medicine composition of the invention has the functions of dilatating coronary, increasing the flow rate of coronary, inhibiting platelet aggregation, decreasing blood viscosity, reducing the formation of thrombus through improving hemorheology and microcirculation, improving the blood supply function of the heart, reducing cerebral vascular resistance, increasing cerebral vascular blood flow, improving the microcirculation of the brain, etc.

The invention discloses a gastrodia elata beverage. The gastrodia elata beverage is prepared from 8 to 18 parts of gastrodia elata, 6 to 10 parts of raw radix paeoniae alba, 6 to 10 parts of salviae miltiorrhizae, 3 to 12 parts of white granulated sugar, 0.5 to 1 part of juice, 1 to 2 parts of honey and 70 to 100 parts of water. The gastrodia elata beverage has the effects of increasing cerebral blood flow, lowering cerebral vascular resistance, slightly concentrating cerebral vessels, lowering blood pressure, retarding heart rate and protecting myocardial ischemia.

The invention discloses a traditional Chinese medicine composition for preventing and treating vascular dementia. The traditional Chinese medicine composition for preventing and treating vascular dementia comprises ginseng, gastrodia elata, Euonymus alatus and Ligusticum wallichii. The composition can be prepared into Chinese herbal preparation crude drug for preventing and treating vascular dementia. The ginseng and the Ligusticum wallichii are extracted with alcohol, the gastrodia elata and the Euonymus alatus are extracted with water, the obtained alcohol extract and the obtained water extract are mixed, the mixture is dried under vacuum and then is pulverized to obtain the final product, and the composition can be directly taken orally or is prepared into other dosage forms such as granules, capsules, soft capsules, electuaries, pills and decocted extracts. The composition is completely prepared from natural medicinal plants, does not contain hormones, and does not contain other chemical synthetic products such as pigment, and even if a patient orally takes the composition continuously, no toxic and side effect is performed on the human body. The traditional Chinese medicine composition contains various easily absorbable ingredients such as ginsenoside, chuanxiongol, chuanxiongzine, gastrodin and quercetin, can be effectively used for treating the vascular dementia, increases cerebral blood flow, reduces cerebral vascular resistance, improves body immunocompetence, and has effects of tonifying deficiency, promoting intelligence, suppressing the hyperactive liver, subsiding Yang, dispelling blood stasis and dredging collaterals.

The medicine for treating cerebral infarction, coronary heart disease and angina pectoris is prepared with red peony root in 1 weight portions and notoginseng in 2-6 weight portions as material. Animal experiments show that the medicine of the present invention can reduce cerebral infarction area, increase cerebral flow, reduce cerebral vascular resistance, resist acute myocardial ischemia, increase blood flow of coronary artery, reduce thromosis, lower fibrinogen, blood viscosity, etc.

The invention discloses a flavonoid glycoside red yeast rice lovastatin and a preparation method thereof. The flavonoid glycoside red yeast rice lovastatin is prepared from 55-60% of functional red yeast rice extract and 40-45% of ginkgo leaf extract. The ginkgo leaf flavonoid glycoside composite red yeast rice lovastatin capsule prepared by mixing, capsulation and sterile packaging is convenient for the patient to carry about and convenient for mastering the dose, and is capable of avoiding generating cholesterol, increasing the cerebrovascular flow, lowering the cerebral vascular resistance, improving the cerebrovascular circulatory function, protecting the brain cells, protecting the patient from ischemic injuries, expanding the coronary artery, preventing angina pectoris and myocardial infarction, inhibiting the platelets from aggregation, preventing thrombosis, clearing away harmful oxyradicals and enhancing the immunological competence. The flavonoid glycoside red yeast rice lovastatin has expected curative effects on coronary heart disease, angina pectoris, cerebral arteriosclerosis, senile dementia, hypertension and other diseases.

The invention discloses a ginkgo leaf flavonoid glycoside composite red yeast rice lovastatin capsule, which comprises 55%-60% of a functional red yeast rice extract and 40%-45% of a ginkgo leaf extract. The ginkgo leaf flavonoid glycoside composite red yeast rice lovastatin capsule is prepared by the technological steps of mixing, capsule making, and sterilization packaging, is effectively convenient for patients to take along and master the dosage, can prevent generation of cholesterol, increase cerebrovascular flow, reduce cerebrovascular resistance, improve cerebrovascular circulation function, protect brain cells against ischemic damage, expand coronary arteries, prevent angina pectoris and myocardial infarction, inhibit platelet aggregation, prevent thrombosis, eliminate harmful oxidation free radicals, and improve immunocompetence, and has magic curative effects on coronary heart disease, angina pectoris, cerebral arteriosclerosis, senile dementia and hypertension, etc.

The present invention belongs to medical technique field, a medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation and application thereof and preparation containing the medicinal composition are disclosed. Constitution of raw material medicine containing medicinal components used for preparing the medicinal composition is: fructus trichosanthis 100 to 2000 shares, safflower 100 to 1500 shares, or is: fructus trichosanthis extraction 2 to 160 shares, safflower yellow pigment 1 to 45 shares. The medicinal composition can be prepared into various pharmaceutically any acceptable preparations, optimizing injection or oral preparation. The medicinal composition of the present invention has effects such as dilating coronary artery, increasing coronary flow, inhibiting thrombocyte coagulation, decreasing blood viscosity, improving hemorheology and microcirculation, reducing thrombosis, improving heart blood-supplying function, decreasing cerebrovascular resistance, increasing cerebrovascular flow, improving brain microcirculation and etc.

The invention discloses an application of rhEGF (recombinant human Epidermal Growth Factor) in preparation of a medicament or health product for preventing and treating cerebral ischemia. A pharmacological research shows that the rhEGF has a certain treatment effect on acute/chronic ischemic cerebrovascular diseases, and the medicament can pass through a blood brain barrier, is mainly distributed at a cerebral hemisphere, a brain stem and the like, has an effect of relieving spasm of vascular smooth muscles, and can expand small blood vessels, reduce cerebral vascular resistance, increase the cerebral blood flow, protect endothelial cells and improve microcirculation. The medicament can increase cerebral perfusion of a distant part after MCAO (middle cerebral artery occlusion), resist cell apoptosis, protect neurons of the distant part, and reduce lost contact damages, caused by interruption of a nerve fiber conduction path, to brain tissues of the distant part. Therefore, the medicament can play a certain part in clinical prognosis after improvement of apoplexy by reducing brain dysfunctions of the distant part.